Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha.
about
Cancer as a metabolic diseaseHypoxia-inducible factors as molecular targets for liver diseasesPotential mechanisms of hepatitis B virus induced liver injuryRisk of echocardiographic pulmonary hypertension in individuals with human immunodeficiency virus-hepatitis C virus coinfection.Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma.HIF-1alpha: a valid therapeutic target for tumor therapyHepatitis B virus protein X-induced expression of the CXC chemokine IP-10 is mediated through activation of NF-kappaB and increases migration of leukocytes.Hypoxia inducible factor-1 alpha activation of the JCV promoter: role in the pathogenesis of progressive multifocal leukoencephalopathyMolecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.Overexpression of cyclooxygenase-2 in noncancerous liver tissue increases the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis.Angiogenesis: multiple masks in hepatocellular carcinoma and liver regeneration.Carbon monoxide promotes VEGF expression by increasing HIF-1alpha protein level via two distinct mechanisms, translational activation and stabilization of HIF-1alpha protein.Targeted genes and interacting proteins of hypoxia inducible factor-1.Hepatitis B virus X protein induces expression of Fas ligand gene through enhancing transcriptional activity of early growth response factor.Differential functions of C- and N-terminal hepatitis B x protein in liver cells treated with doxorubicin in normoxic or hypoxic condition.Tumour suppressor HLJ1: A potential diagnostic, preventive and therapeutic target in non-small cell lung cancerHepatitis B virus X protein and the estrogen receptor variant lacking exon 5 inhibit estrogen receptor signaling in hepatoma cellsHypoxia-Inducible Factor (HIF) as a Pharmacological Target for Prevention and Treatment of Infectious DiseasesThe X protein of hepatitis B virus inhibits apoptosis in hepatoma cells through enhancing the methionine adenosyltransferase 2A gene expression and reducing S-adenosylmethionine production.Tumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinoma.Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib.Hepatitis B virus promotes angiopoietin-2 expression in liver tissue: role of HBV x proteinHypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do!Modulation of apoptotic signaling by the hepatitis B virus X protein.Hedgehog signaling blockade delays hepatocarcinogenesis induced by hepatitis B virus X protein.Chronic hepatitis B in hepatocarcinogenesisA network-based maximum link approach towards MS identifies potentially important roles for undetected ARRB1/2 and ACTB in liver cancer progression.Viral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma.BC-box protein domain-related mechanism for VHL protein degradation.Interdependence of hypoxic and innate immune responsesTumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.Hypoxic and highly angiogenic non-tumor tissues surrounding hepatocellular carcinoma: the 'niche' of endothelial progenitor cells.Hepatocellular carcinoma: the point of view of the hepatitis B virus.Wild type HBx and truncated HBx: Pleiotropic regulators driving sequential genetic and epigenetic steps of hepatocarcinogenesis and progression of HBV-associated neoplasms.Hypoxia inducible factors in hepatocellular carcinomaDissecting the pleiotropic actions of HBx mutants against hypoxia in hepatocellular carcinoma.A compendium of proteins that interact with HIF-1α.Development of an oncolytic herpes simplex virus using a tumor-specific HIF-responsive promoter.NF-kappaB signaling mediates the induction of MTA1 by hepatitis B virus transactivator protein HBx.Activation of hypoxia-inducible factor 1 in human T-cell leukaemia virus type 1-infected cell lines and primary adult T-cell leukaemia cells.
P2860
Q21245061-DABB254C-5AA9-45DB-9A9B-C17399BEB731Q26752304-BC564C5F-912A-4B78-88F7-4B1E97D49E20Q27014079-A8D4AF5B-F80F-444A-A687-9877410BDC21Q30397068-33BD8E0F-A4C1-4549-829B-47DC3FEF06C1Q33289829-BB703305-7326-4760-B438-7015687BDDA7Q33746822-B124B15A-4D95-4E3B-9979-AD2453482962Q33782559-B88E66CD-ABDC-491F-8060-035317191A33Q33796549-C3A02E35-D176-4D87-B25B-94D5ED41CD15Q33855801-854EE0A7-930A-4FED-9799-76F345FD43CAQ34053320-8AA00257-16F1-4D0F-B385-C37A76B942C2Q34130424-4EC37101-C4FC-4C81-AC69-5F7C1EBE5D11Q34186417-23F5835F-09D3-4339-A7A0-1B30787A95D9Q34286796-48EEF467-5855-4A78-8338-B0C7A6201BB0Q34324015-F65A3F31-8A09-4AE6-8BD5-84232AC3DF11Q34499932-1A21C204-3A34-4220-9B33-528A80774BD2Q34657698-6627D8F0-16F8-4690-AA09-4C70303563CAQ34666783-4BD74FFC-6E2A-49DB-9DC5-125934EC818FQ34726144-66C455E6-7712-4504-BB53-D75322E6907BQ34948099-096386FF-C384-442A-834E-624EF711568EQ35010488-50F50D43-1790-4DF0-AEF0-413A3DEF8214Q35184195-31D0568A-1DB0-4B87-93F8-50BB28653C8BQ35222133-CB3983C8-72DF-4DB0-BFFA-C66218C4F6FEQ36084438-9A5B08C5-299D-432B-8D8F-9FAE70D58BA4Q36432730-58F51672-ED6C-4FF8-8762-E3F454151965Q36463282-7B4CE736-4FEC-4AAF-A0AB-0A8342339C80Q36557635-4B393403-F0C1-4E92-9CFB-46A0B8576DC0Q37201047-B992494D-C896-46F7-A18E-5DD68DC998FCQ37281965-B3F4040E-E724-4F57-94F9-839BB1BFB204Q37318235-44F01616-13FA-4FBE-8D9C-0C7B9E3E5B3DQ37586121-A1571A0D-034B-4C62-AB34-BCCCABA778C8Q37810431-DD8570DF-E370-4649-B485-B670E7309A13Q37820212-E4D9D0B7-825D-4948-A795-4D71029B7E8BQ37888329-99C87041-B1CB-4DCD-B108-13B92389EB7EQ38643087-FD48FB4C-C568-4C17-B656-5092906A70D1Q38685135-8592988B-E8BB-4D6A-9067-860AFBB68ADBQ38961911-D329F6ED-CBD4-4146-941A-00A4D11CFFAEQ39197245-4BBF84B9-417E-4640-99A2-5F655737F9C6Q39646942-01E6C3BB-228E-4EC4-984A-3A68969A1540Q39725462-780AEA04-5349-49BF-A88B-FBFFFE27754CQ40118264-A05D6ED0-4F62-45A1-856F-4C9BBFB8D801
P2860
Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Hepatitis B virus X protein in ...... poxia-inducible factor-1alpha.
@en
type
label
Hepatitis B virus X protein in ...... poxia-inducible factor-1alpha.
@en
prefLabel
Hepatitis B virus X protein in ...... poxia-inducible factor-1alpha.
@en
P2093
P356
P1433
P1476
Hepatitis B virus X protein in ...... poxia-inducible factor-1alpha.
@en
P2093
Chul Woo Kim
Chul-Ho Jeong
Dae-Yeul Yu
Eun-Joung Moon
Joo-Won Jeong
Kwang Rok Kim
Kyu-Won Kim
Seishi Murakami
P304
P356
10.1096/FJ.03-0153FJE
P407
P577
2003-12-19T00:00:00Z